具有抗肿瘤免疫治疗作用的铂类药物研究进展OA北大核心CSTPCD

As potential immunomodulators,platinum-based drugs could trigger immunogenic cell death(ICD).Hence,combination of platinum-based chemotherapy and immunotherapy could have better synergistic anticancer effect.Pt(Ⅱ)-based drugs are the most common chemotherapeutic agents in cancer treatment yet with limited clinical application due to their toxic side-effects and drug resistance.Pt(Ⅳ)complexes have been widely investigated in the past decades due to their kinetic inertness and unique mechanisms.This article summarizes the progress in the pharmacological activities and mechanisms of Pt(Ⅳ)antitumor complexes via introducing different immunomodulators into chemotherapeutic agents in literature over recent years and highlights the potential targets and molecular signaling pathways so as to provide some reference for further development and potential clinical application of platinum-based chemo-immunotherapeutic agents.